Literature DB >> 23050868

Design of a heterotetravalent synthetic allergen that reflects epitope heterogeneity and IgE antibody variability to study mast cell degranulation.

Michael W Handlogten1, Tanyel Kiziltepe, Basar Bilgicer.   

Abstract

The present paper describes the design of a HtTA (heterotetravalent allergen) as a multi-component experimental system that enables an integrative approach to study mast cell degranulation. The HtTA design allows presentation of two distinct haptens, each with a valency of 2, thereby better reflecting the complexity of natural allergens by displaying epitope heterogeneity and IgE antibody variability. Using the HtTA design, synthetic allergens HtTA-1 and HtTA-2 were synthesized to model a combination of epitope/IgE affinities. HtTA-1 presented DNP (2,4-dinitrophenyl) and dansyl haptens (Kd=22 and 54 nM for IgEDNP and IgEdansyl respectively) and HtTA-2 presented dansyl and the weak-affinity DNP-Pro (DNP-proline) haptens (Kd=550 nM for IgEDNP). Both HtTAs effectively induced degranulation when mast cells were primed with both IgEDNP and IgEdansyl antibodies. Interestingly tetravalent DNP-Pro or bivalent dansyl were insufficient in stimulating a degranulation response, illustrating the significance of valency, affinity and synergy in allergen-IgE interactions. Importantly, maximum degranulation with both HtTA-1 and HtTA-2 was observed when only 50% of the mast cell-bound IgEs were hapten-specific (25% IgEdansyl and 25% IgEDNP). Taken together, results of the present study establish the HtTA system as a physiologically relevant experimental model and demonstrates its utility in elucidating critical mechanisms of mast cell degranulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23050868      PMCID: PMC3609652          DOI: 10.1042/BJ20121088

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  Transmembrane signaling: the joy of aggregation.

Authors:  H Metzger
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

2.  Rat basophil leukaemia (RBL) cells sensitized with low affinity IgE respond to high valency antigen.

Authors:  A M Collins; M Basil; K Nguyen; D Thelian
Journal:  Clin Exp Allergy       Date:  1996-08       Impact factor: 5.018

3.  Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2.

Authors:  J S Stanley; N King; A W Burks; S K Huang; H Sampson; G Cockrell; R M Helm; C M West; G A Bannon
Journal:  Arch Biochem Biophys       Date:  1997-06-15       Impact factor: 4.013

4.  A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain.

Authors:  D N Posnett; H McGrath; J P Tam
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

5.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

6.  Highly effective poly(ethylene glycol) architectures for specific inhibition of immune receptor activation.

Authors:  Emily J Baird; David Holowka; Geoffrey W Coates; Barbara Baird
Journal:  Biochemistry       Date:  2003-11-11       Impact factor: 3.162

7.  Oligomerization and ring closure of immunoglobulin E class antibodies by divalent haptens.

Authors:  R Schweitzer-Stenner; A Licht; I Lüscher; I Pecht
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

8.  The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness.

Authors:  Leo C James; Dan S Tawfik
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

Review 9.  The uses and properties of PEG-linked proteins.

Authors:  C Delgado; G E Francis; D Fisher
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1992       Impact factor: 4.889

Review 10.  Chemistry for peptide and protein PEGylation.

Authors:  M J Roberts; M D Bentley; J M Harris
Journal:  Adv Drug Deliv Rev       Date:  2002-06-17       Impact factor: 15.470

View more
  8 in total

1.  Interplay between Affinity and Valency in Effector Cell Degranulation: A Model System with Polcalcin Allergens and Human Patient-Derived IgE Antibodies.

Authors:  Gintare Bucaite; Tara Kang-Pettinger; Jorge Moreira; Hannah J Gould; Louisa K James; Brian J Sutton; James M McDonnell
Journal:  J Immunol       Date:  2019-08-28       Impact factor: 5.422

2.  A heterobivalent ligand inhibits mast cell degranulation via selective inhibition of allergen-IgE interactions in vivo.

Authors:  Michael W Handlogten; Ana P Serezani; Anthony L Sinn; Karen E Pollok; Mark H Kaplan; Basar Bilgicer
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

3.  Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation.

Authors:  Michael W Handlogten; Tanyel Kiziltepe; Ana P Serezani; Mark H Kaplan; Basar Bilgicer
Journal:  Nat Chem Biol       Date:  2013-10-06       Impact factor: 15.040

4.  Nanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulation.

Authors:  Peter E Deak; Maura R Vrabel; Vincenzo J Pizzuti; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-13

5.  Two-allergen model reveals complex relationship between IgE crosslinking and degranulation.

Authors:  Michael W Handlogten; Peter E Deak; Basar Bilgicer
Journal:  Chem Biol       Date:  2014-10-09

6.  Optimal aggregation of FcεRI with a structurally defined trivalent ligand overrides negative regulation driven by phosphatases.

Authors:  Avanika Mahajan; Dipak Barua; Patrick Cutler; Diane S Lidke; Flor A Espinoza; Carolyn Pehlke; Rachel Grattan; Yuko Kawakami; Chang-Shung Tung; Andrew R M Bradbury; William S Hlavacek; Bridget S Wilson
Journal:  ACS Chem Biol       Date:  2014-05-15       Impact factor: 5.100

Review 7.  Recent advances in engineering polyvalent biological interactions.

Authors:  Chad T Varner; Tania Rosen; Jacob T Martin; Ravi S Kane
Journal:  Biomacromolecules       Date:  2014-11-26       Impact factor: 6.988

8.  Determination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen Platform.

Authors:  Peter E Deak; Maura R Vrabel; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.